Charmingly Eccentric: Journey Medical Corporation to Participate in Lake Street Capital Markets’ 8th Annual Best Ideas Growth (BIG) Conference

Charmingly Eccentric: A Look Into Journey Medical Corporation’s Latest Announcement A New Beginning On September 9, 2024, Scottsdale, Arizona-based Journey Medical Corporation made waves with their latest announcement. The commercial-stage pharmaceutical company, known for its focus on dermatological treatments, revealed that President and CEO Claude Maraoui would be attending the Lake Street Capital Markets 8th…

Read More

Volato Takes Big Step Towards Compliance: NYSE-American Accepts Plan

Volato Group, Inc Announces Plan of Compliance Accepted by NYSE American ATLANTA–(BUSINESS WIRE)–Volato Group, Inc (“Volato,” or the “Company”) (NYSE American: SOAR), today announced that the NYSE American LLC (the “NYSE American”) has accepted the Company’s plan of compliance for continued listing on the exchange. As previously reported, on June 18, 2024, the Company received…

Read More

Breaking News: RXO Announces Common Stock Offering and Financing for Acquisition of Coyote Logistics from UPS!

What’s Happening with RXO? Exciting News from RXO Have you heard the latest news from RXO? The leading provider of asset-light transportation solutions, RXO, has just announced its plans to make an offering of $350,000,000 of shares of its common stock. This news has definitely caught the attention of investors and analysts alike. RXO’s common…

Read More

Aquestive Therapeutics to Host Virtual Investor Day: Exciting Pipeline Updates to be Revealed on September 27th!

Aquestive Therapeutics Investor Day: A Look at the Future of Pharmaceutical Innovation A Breakthrough in Medicine On September 27, 2024, Aquestive Therapeutics, Inc. will host a virtual investor day to discuss the latest updates on their pipeline, including the revolutionary products Anaphylm™ (epinephrine) Sublingual Film and AQST-108 (epinephrine) Topical Gel. These products, developed through the…

Read More

Protara Therapeutics Makes Big Moves: First Cohort Complete in Phase 2 STARBORN-1 Trial for TARA-002 Treatment in Kiddos with Lymphatic Malformations!

Welcome to the Wacky World of Protara Therapeutics! Breaking News Alert: Protara Therapeutics Completes Phase 2 Trial for Pediatric Patients Hey there, folks! Did you hear the latest news buzzing around the medical world? Protara Therapeutics, a company on a mission to revolutionize cancer and rare disease treatment, just hit a major milestone in their…

Read More

Exploring a Sale: Daventry Group Urges Kinaxis Board to Take Action

Kinaxis: A Software Asset with Potential Challenges and Opportunities Kinaxis is a best-in-class software asset in a strategically important category, specializing in supply chain planning. However, the company has been plagued by years of poor execution and mismanagement under the current board’s supervision. With the recent abrupt departures of Kinaxis’s Chief Executive Officer and Chief…

Read More

Intuitive Machines Unveils New Leadership Appointments: A Promising Step Towards the Future

Exciting Leadership Changes at Intuitive Machines September 09, 2024 Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW) Intuitive Machines, Inc., a prominent space exploration, infrastructure, and services company, recently announced some significant leadership changes that are set to take effect on September 16, 2024. Pete McGrath, the current Senior Vice President and Chief Operating Officer, will be…

Read More